|Last Price$65.60||Day Change (%)0.85%|
|Open Price$65.35||Day Change ($)0.55|
|Day Range65.30–65.88||52-Week Range53.08–70.66|
As of Fri 03/07/2014 04:19 PM EST | USD
Research and Markets: Global Smart Homes, Buildings (Energy Efficient, Automated) Market Report 2013-2020
Accuvant Reinforces Commitment to the C-Suite with Two New Hires
Good day, ladies and gentlemen. Thank you for standing by. Welcome to the Emerson's Investor Conference Call. During today's presentation by Emerson management, all parties will be in a listen-only mode. Following the presentation, the conference will be opened for questions.
Slowly and steadily, industrial demand is continuing unabated, both in the U.S. and, surprisingly, in Europe.
The newly public AbbVie's dividend will be too concentrated to a single drug, while the payout from the remaining Abbott entity won't be as generous as in years past, according to Morningstar's Josh Peters.
Disclaimer: The opinions in this document are for informational and educational purposes only and should not be construed as a recommendation to buy or sell the stocks mentioned or to solicit transactions or clients. Past performance of the companies discussed may not continue and the companies may ...
The current industrial slowdown could persist for several additional quarters, but we think pockets of value exist.
Which stocks have performed best, and what can investors expect going forward?